Login / Signup
Industries
Technology
Energy
Media
Finance
Green Issues
China
All Concepts
Metals
Energy
Meats
Grains
Softs
ETFs
Indices
Currencies
Geographies
Exchanges
Rates
How To Invest
Personal Finance
Options 101
Definitions
close
close
Send us Feedback
ARIAD Pharmaceuticals (ARIA)
SUMMARY
BULLS
BEARS
DATA CENTRAL
STOCK CHART
BALANCE SHEET
INCOME STMT
CASH FLOW
Key Metrics for ARIA as compared to
Top Competitors
Biotechnology
Pharma & Healthcare
All values TTM unless otherwise noted (*)
INDUSTRY METRICS
No data.
Revenue
Net Income
INCOME STATEMENT (
See all
)
Revenue
►
6.15M
AVG
EBITDA
►
-58.6M
AVG
Net Income
►
-62.0M
AVG
Revenue Growth
►
1.1%
AVG
Operating Margin
►
-879.8%
AVG
Net Margin
►
-1008.2%
AVG
Revenue, Net Income, and Net Margin
Revenue, Gross Profit, and Gross Margin
Ebit
Income Before Taxes
Net Income from Continuing Ops
Interest Coverage
Operating Expenses
Research & Development
SG&A
Amortization & Depreciation
BALANCE SHEET (most recent quarter) (
See all
)
Debt / Equity
►
-2.18
Current Ratio
►
2.28
AVG
Quick Ratio
►
2.16
AVG
Interest Coverage Ratio
►
-271
LOW
Book Value Per Share
►
-0.635
Cash Per Share
►
0.504
Loading...
STOCK SUMMARY
Open
2.20
Day Range
2.22
-
2.35
52 Week Range
0.72
-
3.48
Volume
598K
Avg Volume (3 mo)
2.56M
Shares Outstanding
113M
Market Cap
250M
VALUATION
Price to Earnings (P/E)
►
-4.43
Price to Book (P/B)
►
-3.80
Price to Sales (P/S)
►
44.7
AVG
Return on Assets (ROA)
►
-73.3%
AVG
Return on Equity (ROE)
►
-2138.8%
VERY LOW
EV/EBITDA
►
-5.84
Dividend Yield
0%
AVG
ANALYST RECOMMENDATIONS
OWNERSHIP
Net Insider Buying 3mo
-2.2%
Net Insider Buying 6mo
112.1%
Net Insider Buying 1yr
112.1%
Held by insiders
2.8%
Held by institutions
27.6%
No Sales Breakout Data.